North America Immune Health Supplements - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The north america immune health supplements market size was valued at USD 4.58 billion in 2025 and estimated to grow from USD 5.01 billion in 2026 to reach USD 7.81 billion by 2031, at a CAGR of 9.29% during the forecast period (2026-2031). This report is Segmented by Product Type (Vitamins and Minerals, Herbal/Botanical Extracts, and More), Form (Capsules and Softgels, Tablets, and More), Distribution Channel (Supermarkets/Hypermarkets, Specialty and Health Stores, and More), and Geography (United States, Canada, Mexico, Rest of North America). The Market Forecasts are Provided in Terms of Value (USD).

North America Immune Health Supplements Market Trends and Insights

Preventive Healthcare Trends Strengthen Immune Supplement Market

The prevalence of chronic conditions among US adults reached 76.4% in 2023, according to the Centers for Disease Control and Prevention, reflecting an upward trend from previous years. Among young adults aged 18-34, chronic condition rates increased from 52.5% to 59.5% between 2013-2023, leading this demographic to seek immune support products. The rising health consciousness has prompted consumers to take proactive measures in managing their well-being through dietary supplements and preventive healthcare solutions. With chronic diseases contributing USD 4.5 trillion to annual healthcare costs, consumers are increasingly adopting preventive health measures through supplements to potentially reduce their long-term medical expenses. This shift in health management approach is particularly notable among Millennials, who recognize the connection between gut health and overall wellness. Their growing awareness has accelerated the demand for multifunctional products that combine immune support with mental health and digestive benefits, reflecting a more holistic approach to health maintenance.

Growing Demand for Vitamin D Supplements Among Elderly for Bone Health

According to Health Canada data from 2024, approximately 19% of Canadians have insufficient vitamin D levels for optimal bone health. Vitamin D supplementation addresses bone integrity and immune function concerns in elderly populations, particularly those over 65 years of age. The Food and Drug Administration reported in 2024 that over 10 million Americans have osteoporosis, with the highest prevalence among postmenopausal women. The demand for vitamin D supplements stems from multiple factors, including age-related bone density loss, hormonal changes during menopause, interactions with prescription medications, reduced outdoor activity, and dietary insufficiencies. Geographic variations in vitamin D deficiency rates across northern latitudes create significant market opportunities, particularly in Canada, where limited seasonal light exposure between October and March necessitates consistent year-round supplementation to maintain adequate vitamin D levels.

Stringent Labeling and Health Claims

The complex regulatory landscape across North America creates significant compliance challenges that affect market growth and innovation in the immune supplements industry. The FDA's revised "healthy" claim requirements, implemented in December 2024, establish strict nutritional criteria that many immune supplements struggle to meet. The FDA's structure/function claim regulations require manufacturers to provide substantiation while avoiding disease-related terminology that could classify products as unapproved drugs. Health Canada's Natural Health Products Regulations further complicate pan-North American distribution by requiring Natural Product Numbers (NPNs), which demand comprehensive safety and efficacy documentation. Small companies without dedicated compliance departments face a disproportionate burden, which can restrict market diversity. In Mexico, COFEPRIS regulations mandate front-of-pack warning labels for products exceeding specific nutrient thresholds, which may influence consumer perceptions of immune supplements with higher vitamin content. These regulatory frameworks create market entry barriers that favor established companies with existing compliance systems while potentially limiting innovation from new market entrants.

Other drivers and restraints analyzed in the detailed report include:

• Rising Chronic Disease Rates
• Increased Use of E-Commerce and DTC Brands
• High Market Competition

Segment Analysis

The vitamins and minerals segment dominated the North America immune health supplements market in 2025, accounting for 31.48% of revenue, driven by physician acceptance and comprehensive nutritional benefits. The probiotics segment is projected to grow at a 9.42% CAGR, gaining prominence as research advances in gut-immune system interactions. New probiotic strains, including Faecalibacterium duncaniae and Bacteroides dorei, demonstrate the industry's shift toward targeted immunity benefits. The market continues to evolve with the introduction of postbiotics and synbiotics in the "Others" category. Technical advances in microencapsulation technology improve probiotic survival rates in the digestive system, while liposomal delivery systems enhance vitamin absorption. The market supports premium pricing for products with strong scientific validation.

The market structure features strategic partnerships between ingredient suppliers, contract manufacturers, and finished-product companies. For example, Cargill's EpiCor postbiotic is now available in multiple product formats, including gummies, capsules, and powders, through various partnerships. Botanical extracts maintain a stable market presence among consumers seeking natural immunity solutions, while omega-3 products combine cardiovascular and immune health benefits. While probiotics demonstrate the highest growth rate, ongoing innovation across categories ensures vitamins remain fundamental to the North America immune health supplements market through 2030.

Complete Report Scope:

• By Product Type
  • Vitamins and Minerals
  • Herbal/Botanical Extracts
  • Probiotics
  • Omega-3 Fatty Acids
  • Others
• By Form
  • Capsules and Softgels
  • Tablets
  • Gummies
  • Powders
  • Others
• By Distribution Channel
  • Supermarkets/Hypermarkets
  • Specialty and Health Stores
  • Online Stores
  • Other Distribution Channels
• By Geography
  • United States
  • Canada
  • Mexico
  • Rest of North America

List of Companies Covered in this Report:

• Amway Corp (Nutrilite)
• BayerAG
• Herbalife Nutrition Ltd.
• DSM-Firmenich
• NOW Foods
• Glanbia plc
• Nestlé SA
• PfizerInc. (Emergen-C, Centrum)
• PharmaviteLLC (Nature Made)
• GNC HoldingsLLC
• Church & DwightCo.Inc. (Vitafusion)
• USANA Health Sciences
• Jamieson WellnessInc.
• Nature’s Way (Schwabe North America)
• The Himalayan Drug Company (Himalaya)
• Life Extension (LEF)
• Abbott Laboratories (Pedialyte Immune)
• BioGaiaAB
• Holland and Barret Inc.
• Vitabiotics

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support